So. Slusser et al., SURVIVAL OF PATIENTS DIAGNOSED WITH COLORECTAL-CANCER THROUGH A TELEVISION-ADVERTISED SCREENING-PROGRAM, The American journal of gastroenterology, 91(8), 1996, pp. 1563-1566
Objectives: Although controversial, fecal occult blood testing (FORT)
is advocated to reduce mortality due to colorectal cancer, Our aim was
to determine whether a television-advertised screening program for co
lorectal cancer using fecal occult blood tests improved survival of pa
tients diagnosed with colorectal cancer, Methods A retrospective analy
sis of the stage and survival of patients diagnosed with colorectal ca
ncer in our 1986 and 1987 screening programs was conducted, The 5-yr s
urvival rate of patients diagnosed with colorectal cancer was determin
ed in our screened population and compared with national survival data
from the National Cancer Institute Surveillance, Epidemiology, End Re
sults (SEER) program, Results: In our screening programs, 75,633 FOBT
were distributed and returned for analysis, Test slides were positive
in 3.3%, Follow-up was available in 121 of 131 patients diagnosed with
colorectal cancer, In our screened population, significantly more col
orectal cancers were identified in a localized stage compared with the
national average (76 vs 37%), Consequently, the percentage of our pat
ients with regional and distant disease was decreased compared with SE
ER data, The overall 5-yr survival rate of patients with colorectal ca
ncer who participated in our screening program was significantly highe
r than the national survival rate (75 vs 59%), Survival of patients ol
der than 75 yr of age with colorectal cancer in our screening program
was not improved, Conclusions: Television-advertised screening for col
orectal cancer using FOBT was effective in recruiting a large number o
f participants, Patients diagnosed with colorectal cancer in our progr
am tended to have early stage disease with improved 5-yr survival, The
results of this study support FOBT as an effective means to reduce th
e mortality of colorectal cancer.